The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires.
about
A randomized trial of bevacizumab for newly diagnosed glioblastomaLongitudinal quality of life data: a comparison of continuous and ordinal approaches.Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients.Joint modeling of longitudinal health-related quality of life data and survival.The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group sUse of quality-of-life outcome assessments in current cancer clinical trials.Health-related quality of life in glioma patients in China.Reliability and validity of the SF-36 Health Survey Questionnaire in patients with brain tumors: a cross-sectional study.Development of the Japanese version of the Pediatric Quality of Life Inventory Brain Tumor ModuleWhole brain radiotherapy after local treatment of brain metastases in melanoma patients--a randomised phase III trialThe validation of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30) in pre-operative patients with brain tumor in China.Chemotherapy for high-grade gliomas.The Brain Symptom and Impact Questionnaire in brain metastases patients: a prospective long-term follow-up studySimultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-lifeTemozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas.Hair-sparing whole brain radiotherapy with volumetric arc therapy in patients treated for brain metastases: dosimetric and clinical results of a phase II trialPalliative care and quality of life in neuro-oncology.Patient-reported outcomes and survivorship in radiation oncology: overcoming the consCritical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerationsPrimary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-diPhase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 9Identifying the needs of brain tumor patients and their caregivers.Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma.Health-related quality of life and other clinical outcome assessments in brain tumor patients: challenges in the design, conduct and interpretation of clinical trials.Quality of life in patients with stable disease after surgery, radiotherapy, and chemotherapy for malignant brain tumourTranslation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran.Neurocognitive functioning and health-related quality of life in patients treated with stereotactic radiotherapy for brain metastases: a prospective study.A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseThe end-of-life phase of high-grade glioma patients: dying with dignity?Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitationsCognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines.Quality of life in brain metastases radiation trials: a literature reviewHemiparesis after Operation of Astrocytoma Grade II in Adults: Effects of Acupuncture on Sensory-Motor Behavior and Quality of LifeValidation of the Korean version of the European Organization for Research and Treatment of Cancer brain cancer module (EORTC QLQ-BN20) in patients with brain tumors.Health-related quality of life in patients with high-grade gliomaDose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.Health-related quality of life of long-term high-grade glioma survivors.
P2860
Q30410163-661DE939-3495-4956-B16B-191996332006Q30829260-E4210E5E-4DDC-4F08-B90F-9AB0ED94B7FDQ30840511-B70EB5A5-F005-4141-8F50-011BF8D1BC8BQ30859974-B4744F5C-235D-4C4E-A330-F2DDB1187026Q31117641-65F16A98-0ED7-4CD6-81B4-9A24A41A57DEQ33583284-B09F802B-ECC0-4CA0-A3E3-5F19473B6BDFQ33611220-A82078E5-AAFA-414F-BC94-9EE059B874C8Q33641018-D00FD6A5-C7CB-4A93-B60C-0F3A980E103EQ33864799-2742DCA1-42DC-4F8F-A92E-00F972DEACDCQ33874477-B2BB930F-B819-4F10-90D3-F12B58343116Q33879843-8AFA10A5-D79D-4F63-A866-198CF034BED8Q33898570-BCD266E0-AFE6-47D5-B2A9-15D13750E614Q33913472-26EC3A92-B996-456E-838D-F819BA167E92Q33946063-A3E60EFA-8728-43DE-B987-F952CA48EB42Q33973844-E62F8C7C-3A60-4D4A-9720-7644EE8DD85CQ33987906-7CD20962-1DC7-47CD-8691-117732C75745Q34019937-D30C67D8-E36B-4CDE-9A93-5D50FEEBCDCFQ34124311-64979DDC-0BAA-4E18-8BE2-61AA3731C7E9Q34418437-9AB44685-2123-465C-8402-5BE6014C1616Q34507660-293ABCE6-1CCD-4957-BC03-B89ADF895EA5Q34666837-1050364E-FB4E-4950-A24D-AD4A78D604A9Q34666843-F05F82A3-DBE5-41A9-B417-E16CFC7BF364Q34679120-1FC88359-3A3F-49EB-A442-B054CF5D0DF8Q34854124-D18DC242-F4B1-48F2-96FD-78016C61597EQ35205868-2F418D89-C724-4BE9-A85F-3064D21E1D5AQ35206232-63808FED-E587-4655-8578-3EE85A5AA319Q35206236-55D14931-3A04-457C-A646-C64B60F3E090Q35452804-B6A47AD5-4478-4A4B-80BA-C544F309308FQ36173330-634CF1C3-90C7-4C99-95D9-E6F046AC9F68Q36618258-D5879152-26D4-4030-A173-5129FAF9726BQ36621800-0DFBEB03-98D6-4C9E-91AB-EDF297579F0EQ36630465-ED004BB1-728E-450C-A2AB-E1D8C2C68BABQ36698177-7CB3F0EB-A37D-4428-A641-5AE4BE9F9342Q36729827-C2048883-083A-42FE-BA44-F0D287A4D5E5Q36971728-0D6D2AFD-CF7C-4C03-AA73-103E4B74A4A6Q36999316-E45A34CB-7980-4034-97D7-2BBFC55F5F97Q37155105-25627305-A2B2-4893-B10D-C5B7244FB126Q37217109-2D8DB97E-A634-4CAB-ACB3-5C2BAB21092EQ37278379-C1702635-A375-4E30-974C-D23D25ADBC8AQ37284231-84DAC48B-4641-47A6-ACB3-6255D7CEBD09
P2860
The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The development and psychometr ...... ancer-specific questionnaires.
@en
type
label
The development and psychometr ...... ancer-specific questionnaires.
@en
prefLabel
The development and psychometr ...... ancer-specific questionnaires.
@en
P2093
P356
P1476
The development and psychometr ...... ancer-specific questionnaires.
@en
P2093
E Newlands
N K Aaronson
P2888
P304
P356
10.1007/BF00435979
P577
1996-02-01T00:00:00Z
P6179
1008379504